Paclitaxel and Bortezomib in Treating Patients With Metastatic or Unresectable Malignant Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Bortezomib
Related studies linked through entity extraction aliases.
Bortezomib and Combination Chemotherapy in Treating Younger Patients With Recurrent, Refractory, or Secondary Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- PHASE2
A Study of the Safety and Pharmacology of SGN-40 Administered in Combination With Bortezomib in Patients With Relapsed or Refractory Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1
Preemptive Strike With Bortezomib in Multiple Myeloma Patients
- Status
- TERMINATED
- Phase
- PHASE3
Bortezomib/Adriamycine/Melfalan/Prednisone (VAMP)/Thalidomide/Cyclophosphamide/Dexamethasone (TaCyDex) or Bortezomib/Melfalan/Prednisone (V-MP)/TaCyDex) in Refractary or Relapsed Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE4
Velcaflagida in Relapsed or Refractary Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Lenalidomide and Dexamethasone With or Without Bortezomib in Treating Patients With Previously Untreated Multiple Myeloma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Velcade®-Melphalan Association in Autologous Stem-Cell Transplantation (ASCT)
- Status
- COMPLETED
- Phase
- PHASE2
Vorinostat and Bortezomib in Treating Patients With Progressive, Recurrent Glioblastoma Multiforme
- Status
- COMPLETED
- Phase
- PHASE2
A Phase I/II Trial of VR-CHOP in Lymphoma Patients
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Rituximab, Lenalidomide, and Bortezomib in Mantle Cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Bortezomib, Cetuximab, and Radiation Therapy With or Without Cisplatin in Treating Patients With Stage IV Head and Neck Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Bortezomib and Cetuximab in Treating Patients With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Bortezomib and Gemcitabine in Treating Older Patients With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Phase II Avastin + Bortezomib for Patients With Recurrent Malignant Glioma
- Status
- COMPLETED
- Phase
- PHASE2
Phase 2 Study of Twice Weekly VELCADE and CAELYX in Patients With Ovarian Cancer Failing Platinum Containing Regimens
- Status
- WITHDRAWN
- Phase
- PHASE2
Cyclophosphamide, Bortezomib, and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
An Open-Label Study to Assess the Effect of CYP3A4 Induction on the Pharmacokinetics of VELCADE (Bortezomib)
- Status
- COMPLETED
- Phase
- PHASE1
Thalidomide Versus Bortezomib in Melphalan Refractory Myeloma
- Status
- COMPLETED
- Phase
- PHASE3
Bortezomib, Ifosfamide, Carboplatin, and Etoposide, With or Without Rituximab, in Treating Patients With Relapsed or Refractory AIDS-Related Non-Hodgkin Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1